MAK520
Monoamine Oxidase (MAO) Inhibitor Screening Kit
sufficient for 100 fluorometric tests
Manufacturer: Sigma Aldrich
Synonym(S): MAO-A Inhibitor Detection Kit
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 KIT | MAK520-1-KIT | In Stock | ₹ 57,531.30 |
MAK520 - 1 KIT
In Stock
Quantity
1
Base Price: ₹ 57,531.30
GST (18%): ₹ 10,355.634
Total Price: ₹ 67,886.934
Quality Level
100
application(s)
pharmaceutical
detection method
fluorometric
relevant disease(s)
Alzheimer′s disease; Parkinson′s disease; depression; migraine disorder; schizophrenia; substance abuse; neurodegenerative disorders; neuropsychiatric diseases; neurological disorders
shipped in
wet ice
storage temp.
−20°C
Related Products
Description
- General description: Monoamine oxidases (MAO) are a family of mitochondrial enzymes that catalyze the oxidative deamination of monoamines. Two isoforms of MAO exist, MAO-A and MAO-B, with different inhibitor selectivity and tissue distribution. MAO dysfunction is thought to be responsible for a number of neurological disorders. Unusually high or low levels of MAOs in the body have been associated with depression, schizophrenia, substance abuse, attention deficit disorder, migraines, and irregular sexual maturation. MAO inhibitors are one of the major classes of drug prescribed for the treatment of depression, Parkinson′s, and Alzheimer′s diseases.
- Features and Benefits: Compatible with high-throughput handling systems.
- Suitability: The kit is suitable for inhibitor screening and evaluation of MAO inhibitors.
- Principle: The Monoamine Oxidase (MAO) Inhibitor Screening Kit provides a convenient fluorometric means to screen for MAO enzyme inhibitors. In the assay, MAO reacts with p-tyramine, a substrate for both MAO-A and MAO-B, resulting in the formation of H2O2, which is determined by a fluorometric method at λEx = 530 nm/λEm = 585 nm.
SAFETY INFORMATION
WGK
WGK 2
Compare Similar Items
Show Difference
Quality Level: 100
application(s): pharmaceutical
detection method: fluorometric
relevant disease(s): Alzheimer′s disease; Parkinson′s disease; depression; migraine disorder; schizophrenia; substance abuse; neurodegenerative disorders; neuropsychiatric diseases; neurological disorders
shipped in: wet ice
storage temp.: −20°C
Quality Level:
100
application(s):
pharmaceutical
detection method:
fluorometric
relevant disease(s):
Alzheimer′s disease; Parkinson′s disease; depression; migraine disorder; schizophrenia; substance abuse; neurodegenerative disorders; neuropsychiatric diseases; neurological disorders
shipped in:
wet ice
storage temp.:
−20°C
Quality Level: 100
application(s): __
detection method: colorimetric
relevant disease(s): neurological disorders; neonatal diseases
shipped in: wet ice
storage temp.: −20°C
Quality Level:
100
application(s):
__
detection method:
colorimetric
relevant disease(s):
neurological disorders; neonatal diseases
shipped in:
wet ice
storage temp.:
−20°C
Quality Level: 100
application(s): agriculturefood and beverages
detection method: colorimetricfluorometric
relevant disease(s): __
shipped in: wet ice
storage temp.: −20°C
Quality Level:
100
application(s):
agriculturefood and beverages
detection method:
colorimetricfluorometric
relevant disease(s):
__
shipped in:
wet ice
storage temp.:
−20°C
Quality Level: 100
application(s): __
detection method: fluorometric
relevant disease(s): neurological disorders
shipped in: wet ice
storage temp.: −20°C
Quality Level:
100
application(s):
__
detection method:
fluorometric
relevant disease(s):
neurological disorders
shipped in:
wet ice
storage temp.:
−20°C